Zymergi LogoCart

483 Document: Acorda Therapeutics, Inc., Jun 18, 2018

FDANews 483 Acorda Therapeutics, Inc. Jun 18 2018 top
Stephen C. Smith FDA Investigator Erik W. Koester FDA Investigator Yaodong Huang FDA Investigator

On Jun 18, 2018, the FDA inspected Acorda Therapeutics, Inc.'s Chelsea site. Explore the inspectional observations.